Provided by Tiger Fintech (Singapore) Pte. Ltd.

Palisade Bio Inc.

0.7200
-0.0155-2.11%
Post-market: 0.76000.0400+5.56%19:09 EDT
Volume:24.24K
Turnover:17.46K
Market Cap:3.17M
PE:-0.07
High:0.7775
Open:0.7300
Low:0.6900
Close:0.7355
Loading ...
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Correspondence

Form CORRESP - Correspondence
Dec 12, 2024

Correspondence

Form CORRESP - Correspondence
Dec 12, 2024

Correspondence

Form CORRESP - Correspondence
Dec 12, 2024

Correspondence

Form CORRESP - Correspondence
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 05, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 22, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 21, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Correspondence

Form CORRESP - Correspondence
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]